Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallis

Showing results (381-390 of 476) with videos related to

Pageof 48
Sort By:
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
British Journal of Clinical Pharmacology|July 7, 2026
Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteersAmy Legg, Alison Boast, Kim Piera, et al.
International Journal of Antimicrobial Agents|January 9, 2022
Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept studySuzanne L Parker, Adam D Irwin, Francine Hosking, et al.
Analytical and Bioanalytical Chemistry|January 4, 2022
Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samplesSuzanne L Parker, Steven C Wallis, Cheryl Fourie, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesChandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center StudyNilesh Kumta, Aaron J Heffernan, Menino Osbert Cotta, et al.
International Journal of Antimicrobial Agents|March 30, 2026
Plasma and subcutaneous interstitial fluid vancomycin and gentamicin concentrations in three patients undergoing open abdominal aortic aneurysm repairRochelle Ryan, Paul Jarrett, Melissa Lassig-Smith, et al.
Critical Care (London, England)|May 7, 2013
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Sofie Carrette, Jason A Roberts, et al.
Therapeutic Drug Monitoring|February 9, 2021
A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic AnalysisNicolas Garbez, Litaty C Mbatchi, Emilio Maseda, et al.
BMC Infectious Diseases|July 10, 2012
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeuticJason A Roberts, Jan J De Waele, George Dimopoulos, et al.
Pageof 48

Showing results (381-390 of 476) with videos related to

Sort By:
Pageof 48
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
British Journal of Clinical Pharmacology|July 7, 2026
Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteersAmy Legg, Alison Boast, Kim Piera, et al.
International Journal of Antimicrobial Agents|January 9, 2022
Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept studySuzanne L Parker, Adam D Irwin, Francine Hosking, et al.
Analytical and Bioanalytical Chemistry|January 4, 2022
Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samplesSuzanne L Parker, Steven C Wallis, Cheryl Fourie, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesChandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center StudyNilesh Kumta, Aaron J Heffernan, Menino Osbert Cotta, et al.
International Journal of Antimicrobial Agents|March 30, 2026
Plasma and subcutaneous interstitial fluid vancomycin and gentamicin concentrations in three patients undergoing open abdominal aortic aneurysm repairRochelle Ryan, Paul Jarrett, Melissa Lassig-Smith, et al.
Critical Care (London, England)|May 7, 2013
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Sofie Carrette, Jason A Roberts, et al.
Therapeutic Drug Monitoring|February 9, 2021
A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic AnalysisNicolas Garbez, Litaty C Mbatchi, Emilio Maseda, et al.
BMC Infectious Diseases|July 10, 2012
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeuticJason A Roberts, Jan J De Waele, George Dimopoulos, et al.
Pageof 48